Accumulating evidence has shown that high STAB1 expression correlates with poor prognosis in several cancers, including breast cancer, oral cancer, gastric cancer, hematological malignancies, and metastatic colorectal cancer (CRC) [12,13,14]. This evidence concerns the gene STAB1 and colorectal carcinoma.